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INTRODUCTION: Gynura procumbens has been shown to decrease blood pressure via inhibition of the angiotensin-
converting enzyme. However, other mechanisms that may contribute to the hypotensive effect have not been
studied.
OBJECTIVES: To investigate the cardiovascular effects of a butanolic fraction of Gynura procumbens in rats.
METHODS: Anaesthetized rats were given intravenous bolus injections of butanolic fraction at doses of 2.5–20 mg/
kg in vivo. The effect of butanolic fraction on vascular reactivity was recorded in isolated rat aortic rings in vitro.
RESULTS: Intravenous administrations of butanolic fraction elicited significant (p,0.001) and dose-dependent
decreases in the mean arterial pressure. However, a significant (p,0.05) decrease in the heart rate was observed
only at the higher doses (10 and 20 mg/kg). In isolated preparations of rat aortic rings, phenylephrine (1610-6 M)- or
potassium chloride (8610-2 M)-precontracted endothelium-intact and -denuded tissue; butanolic fraction (1610-6–
1610-1 g/ml) induced similar concentration-dependent relaxation of the vessels. In the presence of 2.5610-3
and 5.0610-3 g/ml butanolic fraction, the contractions induced by phenylephrine (1610-9–3610-5 M) and potassium
chloride (1610-2–8610-2 M) were significantly antagonized. The calcium-induced vasocontractions (1610-4–1610-2 M)
were antagonized by butanolic fraction concentration-dependently in calcium-free and high potassium (6610-2 M)
medium, as well as in calcium- and potassium-free medium containing 1610-6 M phenylephrine. However, the
contractions induced by noradrenaline (1610-6 M) and caffeine (4.5610-2 M) were not affected by butanolic
fraction.
CONCLUSION: Butanolic fraction contains putative hypotensive compounds that appear to inhibit calcium influx via
receptor-operated and/or voltage-dependent calcium channels to cause vasodilation and a consequent fall in blood
pressure.
KEYWORDS: Gynura procumbens; Hypotension; Vasodilatation; Calcium channels, Butanolic fraction.
Hoe SZ, Lee CN, Mok SL, Kamaruddin MY, Lam SK. Gynura procumbens Merr. decreases blood pressure in rats by vasodilatation via inhibition of
calcium channels. Clinics. 2011;66(1):143-150.
Received for publication on August 19, 2010; First review completed on September 17, 2010; Accepted for publication on October 21, 2010
E-mail: hoesz@ummc.edu.my
Tel.: 603 7967 4919
INTRODUCTION
Gynura procumbens Merr. (Compositae), a fast growing
herbaceous plant, is widely found in Borneo, Java, the
Philippines and Peninsular Malaysia. In folk medicine, the
plant is widely used for the treatment of kidney diseases,
rashes and fever,1 and for hypertension.
The hypotensive activity of G. procumbens, first reported
by Lam et al.,2 was shown to be partly due to inhibition of
angiotensin-converting enzyme.3,4 In these studies, the
effect was observed in partially purified aqueous fractions
of crude ethanolic extracts of leaves. In the present study,
however, attempts are made to investigate the vasorelaxant
activity of another fraction that is extracted in butanol (the
butanolic fraction; BU) and to elucidate the underlying
mechanisms involved.
MATERIALS AND METHODS
Plant Material
Whole plants of G. procumbens, excluding the roots, were
collected from the southern part of Peninsular Malaysia and
authenticated at the Institute of Biological Sciences,
University of Malaya. A voucher specimen (KLU 44538)
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was deposited in the Herbarium at the Rimba Ilmu,
University of Malaya.
Extraction and Fractionation of Plant Material
The leaves from the fresh plant were cleaned and dried in an
oven at 40 C˚ and then ground to powder. A crude ethanolic
extract was made by macerating the powder with 96% ethanol
at room temperature for 72 h. The extract was concentrated to
dryness in vacuo; this resulted in a gummy residue that was
then reconstituted in 80% aqueous ethanol. The resulting
solutionwas partitionedwith hexane in order to remove lipids
and waxes from the preparation. The aqueous ethanolic phase
was subjected to evaporation in vacuo that removed the
ethanol and left an aqueous solution that contained an ethanol-
soluble precipitate. This precipitate was subsequently filtered
out and the precipitate-free aqueous solution was further
partitioned against water-saturated n-butanol. The butanolic
phase was dried in vacuo to obtain the BU, with a yield of 2.0%.
In vivo Experiments: Effect of Butanolic Fraction on
the Mean Arterial Pressure and Heart Rate of
Anaesthetized Rats
Animals. Adult male albino Sprague-Dawley (SD) rats,
weighing between 250-300 g were obtained from the
Experimental Animal Center, University of Malaya. They
were kept under standard conditions and given tap water
and standard rat chow ad libitum. All procedures were
approved by the University of Malaya Medical Center
Animal Ethics Committee.
Measurements of Blood Pressure and Heart Rate. The
rats were anaesthetized with sodium pentobarbitone (Rhoˆne
Me´rieux Ltd, Essex, UK), 50 mg/kg, by intraperitoneal
injection. The right jugular vein, left carotid artery and
trachea were surgically exposed. A heparinized polye-
thylene cannula was inserted into the carotid artery for
monitoring the pulsatile blood pressure (BP) via a pressure
transducer connected to the Macintosh MacLab Set-up (AD
Instruments Pty Ltd, Bella Vista, NSW, Australia). The
electrocardiogram (ECG; Lead II) was recorded using
needle electrodes inserted subcutaneously into the limbs
of the animal to monitor heart rate (HR). The jugular vein
was cannulated with heparinized polyethylene tubing for
intravenous (i.v.) injections of the plant extracts. The trachea
was cannulated to facilitate spontaneous respiration. The
animal was kept warm with a heating lamp throughout the
experiment. The set-up was allowed to equilibrate for at
least 30 min before the start of the experiments.
After the equilibration period, the rats (n= 6) were
injected with BU at doses of 2.5–20.0 mg/kg in a volume
of 0.1 ml for each dose. BP was allowed to return to the
resting level before each subsequent injection was adminis-
tered. Changes in BP as a result of administration of the
extracts were obtained by calculating the difference between
the BP before and the lowest BP recorded after the
injections. For controls, rats (n= 6) were similarly injected
with an equivalent volume of the vehicle. The mean arterial
pressure (MAP) was calculated from the pulsatile BP using
the formula: diastolic BP + M pulse pressure.
In vitro Experiments: Studies on Isolated Rat
Thoracic Aorta
Tissue Preparation. Male SD rats (250–300 g) were
sacrificed by exsanguination. The descending thoracic
aorta was isolated and placed in an oxygenated Krebs-
Henseleit (K-H) solution of the following composition (in
mM): NaCl, 118.0; KCl, 4.70; CaCl2, 2.5; MgSO4, 1.2;
KH2PO4, 1.2; NaHCO3, 25.0; glucose, 11; and ascorbic acid,
0.57. The aorta was carefully cleaned of adhering fat and
connective tissue and cut into 2.0–2.5 mm wide transverse
rings. The aortic ring was mounted in an organ bath
containing 10 ml of K-H solution by means of two parallel
L-shaped stainless-steel holders inserted into the lumen.
One of the holders served as an anchor while the other was
connected to a force-displacement transducer to measure
isometric contractile force, as recorded by a MacLab
computer system (AD Instruments). The bath solution was
maintained at 37 C˚ and bubbled continuously with a 95%
O2 and CO2 gas mixture. A basal tension of 1 g was applied.
Each preparation was allowed to equilibrate for 60 min with
changes of bath solution every 15 min before the start of the
experiments. Before each experiment, the aortic rings were
stimulated at least three times with 6610-2 M KCl until a
reproducible contractile response was obtained.
For some preparations, the rings were denuded of
endothelium by inserting a pair of fine forceps into the
lumen of the aorta and gently rotating the aorta around the
forceps. The endothelium-denuded rings were similarly
equilibrated in the organ bath for 60 min. The success of
endothelial denudation of the aortic rings was tested by
adding acetylcholine (1610-6 M) to the organ bath to induce
relaxation in phenylephrine (PE; 1610-6 M)-precontracted
rings. A relaxation of $ 70% of the PE-induced contraction
indicated the presence of an intact endothelial layer, whilst
the lack of any relaxation indicated that the endothelium
was satisfactorily removed.
Appropriate parallel control experiments (n= 6) using
vehicle only were always performed concurrently in order
to correct for possible changes in the sensitivity of the
preparations.
Effects of Butanolic Fraction on Phenylephrine- or Potas-
sium Chloride-precontracted Rings. The intact (n= 8) and
endothelium-denuded (n= 6) aortic rings were precon-
tracted by treatment with PE (1610-6 M) or KCl (8610-2 M).
After the tonic responses had become stable, increasing
concentrations of BU (10-6–10-1 g/ml) were added cumula-
tively.
Effect of Butanolic Fraction Pretreatment on Phenylep-
hrine- or Potassium Chloride-induced Contractions. After
equilibrium, cumulative concentration-response curves for
PE (1610-9–3610-5 M) or KCl (1610-2–8610-2 M) were
determined. The curves were obtained in intact (n= 6) and
denuded (n= 6) rings by stepwise increase in the
concentration of PE or KCl. Additions were made as soon
as a steady response was obtained from the preceding con-
centration. After washing and recovery for 30 min in normal
K-H solution, the tissue was treated with 2.5610-3 or 5610-
3 g/ml of BU and incubated for 30 min. After the incubation
period, the second cumulative concentration-response
curves for PE and KCl were determined again in the
presence of BU. Each preparation was exposed to only one
concentration of BU.
Effect of Butanolic Fraction Pretreatment on Calcium-
induced Contraction in the Presence of High Potassium. To
investigate the inhibitory effects of BU on Ca2+ influx
through the voltage-dependent calcium channel (VDCC),
the denuded aortic rings (n= 6) were exposed to a Ca2+-free
solution in the presence of K+ (6610-2 M) for 60 min. The
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Ca2+-free solution had the same composition as the normal
K-H solution except that CaCl2 was omitted and ethy-
lenediaminetetraacetic acid (EDTA) (1610-4 M) added to
ensure total elimination of extracellular Ca2+. Two succes-
sive cumulative concentration-response curves for Ca2+
(1610-4–1610-2 M) were obtained. The first curve was
obtained in the absence of BU. The aortic rings were then
washed and equilibrated for 60 min in Ca2+-free and high K+
solution. Two different concentrations of BU (2.5610-3 or
5.0610-3 g/ml) or vehicle were added to the bath and
allowed to act for 30 min before a second cumulative
concentration-response curve for Ca2+ was obtained in the
presence of BU or vehicle. Each preparation was exposed to
only one concentration of BU.
Effect of Butanolic Fraction Pretreatment on Calcium-
induced Contraction in the Presence of Phenylephrine. To
elucidate the inhibitory effects of BU on Ca2+ influx through
the receptor-operated calcium channel (ROCC), the experi-
ments were carried out in a Ca2+- and K+-free K-H solution.
This solution had the same composition as the Ca2+-free K-
H solution except that 1.2 mM of KH2PO4 was replaced by
equimolar amount of NaH2PO4.
After equilibration, the aortic rings (n= 6) were washed
with the Ca2+- and K+-free solution. Addition of PE (1610-
6 M) induced transient vasocontraction. As the PE-induced
contraction reached a steady state, cumulative concentra-
tions of Ca2+ (1610-4–1610-2 M) were applied in a stepwise
manner to obtain the first concentration-response curve for
Ca2+. The aortic rings were then washed with normal K-H
solution and incubated for 45 min, after which, the medium
was replaced with the Ca2+- and K+-free solution. After
equilibration for 15 min, BU (2.5610-3 or 5.0610-3 g/ml) or
vehicle were added to the bath and allowed to incubate for
30 min before the addition of PE. Cumulative concentrations
of Ca2+ (1610-4–1610-2 M) were then added to the bath in
the presence of BU or vehicle to obtain the second concen-
tration-response curve. Each preparation was exposed to
only one concentration of BU.
Effect of Butanolic Fraction Pretreatment on Noradre-
naline- or Caffeine-induced Contractions in the Absence of
Extracellular Calcium. In order to investigate whether the
BU could interfere with the Ca2+ release from intracellular
stores, the inhibiting effects of BU on noradrenaline (NA)-
or caffeine-induced contractions in the absence of extracel-
lular Ca2+ were performed.
After equilibrium in normal K-H solution, the endothe-
lium-denuded rings (n= 6) were exposed to Ca2+-free K-H
solution for 15 min, followed by the addition of NA (1610-
6 M) or caffeine (4.5610-2 M) to induce transient contraction.
The rings were then washed with normal K-H solution and
incubated for 45 min to replenish the intracellular Ca2+
stores. Subsequently, the medium was replaced with Ca2+-
free K-H solution. After equilibration for 15 min, the con-
tractile responses to NA or caffeine were tested in the
presence of BU (2.5610-3 or 5.0610-3 g/ml) or vehicle.
Chemicals and Drugs
Heparin was purchased from Leo Pharmaceutical
Products (Ballerup, Denmark). Drugs were obtained from
Sigma Chemical Co. (St Louis, MO, USA). All drugs were
dissolved in distilled water with the exception of caffeine,
which was dissolved in Ca2+-free K-H solution. Other
chemicals and solvents were of analytical grade.
Data Analysis
The vasorelaxant response of BU is expressed as a per-
centage (%) relaxation of the PE- or KCl-induced con-
traction. The pIC50 value (-log IC50) is calculated as the
concentration of BU (g/ml) in the bath solution required to
produce a 50% reduction of the maximal contraction
induced by PE or KCl.
When the cumulative concentration-response curves with
PE, KCl or CaCl2 were compared, the maximal contractile
response (Emax) obtained in the first response curve was
taken as the 100% response and all subsequent contractions
were calculated as a percentage of these values. The pEC50
value (-log EC50) was determined from the EC50 value,
which is the concentration required to produce a half-effect
in the concentration-response curves, calculated from indi-
vidual log concentration-response curves of the PE, KCl or
CaCl2 by sigmoidal non-linear regression analysis within
the 95% confidence intervals using GraphPad PrismH v. 4.00
(GraphPad Software Inc., La Jolla, CA, USA).
When NA or caffeine were used as vasocontractile
agonists, changes in the NA- or caffeine-induced contrac-
tions in the presence of BU or vehicle are expressed as
percentages of the control agonist-induced contractions
(obtained in the absence of BU or vehicle).
Statistical Analysis
All values are expressed as mean¡ SEM for n number of
rats or separate experiments. Statistical differences were
evaluated by analysis of variance (ANOVA) followed by
Duncan’s new multiple-range test and Student’s t-test. A
probability level of less than 0.05 (p,0.05) was considered
to be significantly different. Post-hoc statistical power
analysis was performed for all the experiments conducted
and a value of . 0.8 was considered adequate.
RESULTS
In vivo Experiments: Effects of Butanolic Fraction on
Mean Arterial Pressure and Heart Rate of Rats
Intravenous administrations of BU (2.5–20 mg/kg)
induced immediate and dose-dependent decreases in
MAP and HR (Figure 1). BU-induced hypotension and
bradycardia became significant (p,0.05) at doses of 2.5 and
10.0 mg/kg, respectively. The hypotensive effect was
maximal within the first 20 to 30 s after BU treatment.
Pre-dose baseline levels were fully recovered within 10 min
after BU administration. The effective dose that produced a
50% reduction in the MAP (ED50) was 4.77 mg/kg of BU.
In vitro Experiments: Studies on Isolated Rat
Thoracic Aorta
Effects of Butanolic Fraction on Phenylephrine- or
Potassium Chloride-Precontracted Rings. The BU fraction
at concentrations ranging from 10-6–10-1 g/ml significantly
(p,0.05) inhibited the tonic contractions induced by PE and
KCl in endothelial-intact and endothelial-denuded aortic
rings in a concentration-dependent manner (Figure 2).
The maximal relaxant responses of BU for the intact and
denuded rings precontracted with PE were not signi-
ficantly different (94.86¡ 3.24% and 92.76¡ 4.54%, respec-
tively). Similarly, no differences were found in the pIC50
values for BU in intact or denuded rings (2.46 ¡ 0.04 and
2.38 ¡ 0.03, respectively).
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In aortic rings precontracted with KCl, there was no
difference between the maximal relaxant responses of BU in
intact or denuded rings (86.89 ¡ 8.22 and 81.66 ¡ 4.29%,
respectively). The pIC50 values for BU in aortic ring with
and without endothelium were also not significantly
different (2.11 ¡ 0.06 and 2.19 ¡ 0.07, respectively).
The pIC50 values of BU in PE-precontracted aortic rings
were significantly (p,0.05) higher than that in KCl-
precontracted rings for both intact and denuded prepara-
tions.
Effect of Butanolic Fraction Pretreatment on Phenyle-
phrine- or Potassium Chloride-induced Contractions. Pre-
treatments with BU at 2.5610-3 and 5.0610-3 g/ml for 30 min
potently (p,0.05) inhibited the PE-induced vasocontraction
in a concentration-dependent manner and shifted the
concentration-response curve toward the right in a non-
parallel manner with decreased Emax values in both
endothelium-intact and -denuded aortic preparations
(Figure 3). Table 1 shows the effect of BU on the Emax and
pEC50 values for PE and KCl in endothelium-intact and
endothelium-denuded aortic rings. Although BU did not
alter the pEC50 value for PE in endothelium-intact rings, it
caused a significant (p,0.05) reduction in the pEC50 value
in the denuded rings.
Similarly, pretreatment with BU suppressed (p,0.05) the
cumulative concentration contraction induced by KCl in a
concentration-dependent manner. The Emax values for KCl
in endothelium-intact and endothelium-denuded aortic
rings were significantly (p,0.05) depressed in the presence
of BU. There was a reduction of pEC50 values for KCl in the
presence of BU at 5.0610-3 g/ml in both intact and denuded
rings.
Effect of Butanolic Fraction Pretreatment on Calcium-
induced Contraction in the Presence of High Potassium. As
shown in Figure 4, pretreatment of BU attenuated the CaCl2-
induced contraction of denuded rat aorta exposed to Ca2+-
free medium containing high K+. Preincubation of the
rings with BU at 2.5610-3 and 5.0610-3 g/ml significantly
(p,0.001) reduced the Emax values for CaCl2 in a concen-
tration-dependent manner (Table 2). Similarly, the pEC50
values for CaCl2 were reduced (p,0.001) in the presence of
BU.
Figure 1 - Effects of butanolic fraction (BU) obtained from Gynura procumbens crude ethanolic extract on the mean arterial pressure
(MAP) (a) and heart rate (HR) (b) of anaesthetized rats. Values are mean¡S.E.M. (n=6). *p,0.05 and ***p,0.001, compared with the
controls.
Figure 2 - Concentration-relaxation curves for butanolic fraction (BU) in the isolated rat aortic rings. BU-induced relaxation was studied
on endothelium-intact (Endo +) and endothelium-denuded (Endo -) aortic rings precontracted with either phenylephrine (a) or KCl (b).
Values are mean¡S.E.M. (n=6 - 8).
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Effect of Butanolic Fraction Pretreatment on Calcium-
induced Contraction in the Presence of Phenylephrine. In
Ca2+- and K+-free solution, after PE induced a stable aortic
contraction, Ca2+ at increasing concentrations (1610-4–1610-
2 M) were cumulatively added to the organ bath. A sus-
tained contraction was generated, which increased with the
concentration of Ca2+. Preincubation of the aortic rings with
BU (2.5610-3 and 5.0610-3 g/ml) for 15 min before PE appli-
cation significantly (p,0.05) inhibited the Ca2+-induced
contraction in a concentration-dependent manner (Figure 5).
BU significantly (p,0.05) suppressed the Emax values of
CaCl2 without altering the pEC50 values (Table 3).
Effect of Butanolic Fraction Pretreatment on Noradre-
naline- and Caffeine-induced Contraction in the Absence of
Extracellular Calcium. The results presented in Figure 6
show that the contractions induced by either NA or caffeine
in a Ca2+-free solution were not significantly affected by the
addition of BU.
Figure 3 - Effect of butanolic fraction (BU) on phenylephrine and KCl-induced contraction. Concentration-response curves for both
agonists were determined in endothelium-intact (Endo +) and endothelium-denuded (Endo -) aortic rings in the absence (without BU)
and presence of BU (2.5610-3 or 5.0610-3 g/ml). Values are mean¡S.E.M. (n=6). *p,0.05; **p,0.01 and ***p,0.001 compared with
controls (without BU).
Table 1 - Effect of butanolic fraction (BU) on the Emax and pEC50 values for phenylephrine and KCl in endothelium-intact
(Endo +) or endothelium-denuded (Endo -) aortic rings.
Emax (%) pEC50
BU (6 10-3 g/ml) Endo + Endo - Endo + Endo -
Phenylephrine
0 100 100 7.11 ¡ 0.06 7.88 ¡ 0.14
2.5 78.35 ¡ 6.27* 65.17 ¡ 4.55** 7.01 ¡ 0.11 7.23 ¡ 0.11*
5.0 72.93 ¡ 7.43* 50.51 ¡ 5.75** 6.86 ¡ 0.21 6.96 ¡ 0.13*
KCl
0 100 100 1.57 ¡ 0.01 1.59 ¡ 0.03
2.5 41.81 ¡ 2.01*** 38.42 ¡ 2.21*** 1.65 ¡ 0.04 1.77 ¡ 0.09
5.0 24.81 ¡ 3.21***,++ 25.43 ¡ 2.66 ***,++ 1.42 ¡ 0.44* 1.46 ¡ 0.06*
Values are means ¡ S.E.M. (n = 6).
*P , 0.05; ** P , 0.01 and ***P , 0.001 compared with the control group
++P , 0.01 compared with BU 2.56 10-3 g/ml.
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DISCUSSION
The results (Figure 1) show that BU obtained from the
crude ethanolic extract of G. procumbens may contain
compounds that appear to exert a strong, dose-dependent
and immediate BP-lowering effect in rats, with the maximal
response being reached within approximately 20 s of
administration. The duration of the hypotensive effect
seems to last about 10 min. Significant bradycardia was
also observed at the higher doses (10.0 and 20.0 gm/kg) of
BU, which may contribute to the hypotensive effect.
However, the hypotensive effect could also be brought
about by putative compounds present in BU that act by
reducing the resistance of peripheral blood vessels. In in
vitro studies, BU could cause relaxation in endothelium-
intact and endothelium-denuded aortic rings precontracted
by PE or KCl, suggesting that vasorelaxation could be a
basis for the hypotensive action (Figure 2).
Vascular endothelium plays an important role in control-
ling vascular tone through the secretion of both relaxant and
contractile factors. Endothelial cells respond to chemical and
physical stimulation by producing several potent vasodi-
lator substances such as bradykinin, prostaglandins, in the
form of prostacyclin,5,6 and nitric oxide.7 However, data
presented here seem to suggest that the action of BU is
mediated via a direct effect on the vascular smooth muscle
(VSM) and not through the endothelium. This is a result of
the finding (Figure 2) that relaxation brought about by BU
persisted in both the endothelium-intact and endothelium-
denuded aortic rings, indicating that the endothelium may
not be involved in BU-induced vasorelaxation.
Activation of a1-adrenoceptors on VSM by PE induces
smooth muscle contraction,8 while specific a1-adrenoceptor
antagonists such as prazosin competitively antagonise the
contractile responses to PE by shifting parallel to the right of
the PE concentration-response curve without modifying the
maximal responses.9,10 In this study, however, the BU
fraction at 2.5610-3 and 5.0610-3 g/ml was able not only to
cause a right- and down-shift of the PE concentration-
response curve but also to reduce the maximal response
(Figure 3). This suggests that BU acts as a non-competitive
antagonist against the PE-induced contraction. Therefore,
BU has no specific antagonistic effect on a1-adrenoceptors
and the vasorelaxant effect of BU could not have been
mediated directly via the a1-adrenoceptors.
Vascular smooth muscle contraction is triggered by a rise
in free cytoplasmic Ca2+ level brought about by the opening
of VDCCs and ROCCs11,12 located on cell membranes. These
Figure 4 - Effect of butanolic fraction (BU) on CaCl2-induced
contraction in Ca2+-free solution containing high K+ (60 mM).
Concentration-response curves for CaCl2 were determined in
endothelium-denuded aortic rings in the absence (without BU)
and presence of BU (2.5610-3 or 5.0610-3 g/ml). Values are
mean¡S.E.M. (n=6). ***p,0.001 compared with controls (with-
out BU).
Table 2 - Effect of butanolic fraction (BU) on the Emax and
pEC50 values for CaCl2 in endothelium-denuded aortic
rings in Ca2+-free solution containing high K+.
BU (610-3 g/ml) Emax (%) pEC50
0 100 3.22 ¡ 0.03
2.5 35.68 ¡ 5.69*** 2.83 ¡ 0.09*
5.0 23.37 ¡ 5.31*** 2.93 ¡ 0.17*
Values are means¡ S.E.M. (n= 6).
*P,0.05 and ***P,0.001 compared with the control group
Figure 5 - Effect of butanolic fraction (BU) on CaCl2-induced
contraction in Ca2+- and K+- free solution containing pheny-
lephrine (PE). Concentration-response curves for CaCl2 were
determined in endothelium-denuded aortic rings in the absence
(without BU) and presence of BU (2.5610-3 or 5.0610-3 g/ml).
Values are mean¡S.E.M. (n =6). *p,0.05; and **p,0.01 com-
pared with controls (without BU).
Table 3 - Effect of butanolic fraction (BU) on the Emax and
pEC50 values for CaCl2 in endothelium-denuded aortic
rings in Ca2+- and K+- free solution containing
phenylephrine.
BU (610-3 g/ml) Emax (%) pEC50
0 100 3.37 ¡ 0.07
2.5 71.93 ¡ 5.55* 3.47 ¡ 0.06
5.0 53.78 ¡ 5.31** 5.34 ¡ 0.09
Values are means¡ S.E.M. (n= 6).
*P,0.05 and **P,0.01 compared with the control group
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channels can be activated by high extracellular K+ for
VDCC11 and PE for ROCC,12 but by different mechanisms of
the downstream signalling pathways.13-15 In the present
study, the data (Figure 2) obtained indicated that BU is able
to exert vasorelaxation in the endothelium-intact and
endothelium-denuded aortic rings precontracted with PE
or high K+ in a concentration-dependent manner. In
addition, BU was also able to concentration-dependently
antagonise the contractions induced by PE or KCl in aortic
rings with or without endothelium (Figure 3). These
observations suggest that BU may interfere with the Ca2+
channels of the VSM, resulting in a decrease in the
cytoplasmic Ca2+ levels and, hence, in the contraction.
Indeed, the results of further investigations (Figure 4),
wherein the aortic rings were incubated in the presence of
BU in a medium that is Ca2+-free but with high
K+ or in another that is both Ca2+- and K+-free and con-
taining PE (Figure 5), reveal that BU appears to bring about
relaxation of the VSM by blocking both the VOCC and
ROCC.
The rise in free cytoplasmic Ca2+ level that is necessary for
VSM contraction to occur can also be brought about by
activation of the ryanodine receptor located on sarcoplasmic
reticulum (SR)16,17 by a spike in cytoplasmic Ca2+ (the
calcium-induced calcium release mechanism).18-20 In addi-
tion, activation of the inositol trisphosphate (IP3) receptor
located on the SR can increase the cytoplasmic Ca2+ level as
well. These receptors are sensitive to caffeine for ryano-
dine16,21 and NA for IP3.
22,23 In the present study, the
influence of BU on Ca2+ release from intracellular stores
sensitive to NA and caffeine was analyzed, wherein it was
found that BU did not alter the vasocontraction induced by
NA or by caffeine (Figure 6). Thus, it seems unlikely that the
vasorelaxant effect of BU could involve the reduction of
Ca2+ release from intracellular stores via inhibition of IP3 or
ryanodine receptors.
Another possible mechanism that leads to vasorelaxation
is the opening of potassium channels which would increase
the potassium efflux, leading to membrane repolarization
and/or hyperpolarization.16,24,25 This effect subsequently
lowers the opening probability of VDCC,26 restrains
agonist-induced Ca2+ release from intracellular stores
through inhibition of IP3 formation,
27 decreases the sensi-
tivity of intracellular contractile elements to Ca2+,28 and
accelerates the clearance of intracellular Ca2+ via the Na+/
Ca2+ exchanger.24,25,29 In the current study, BU was shown
to inhibit the Ca2+ influx through VDCC and slightly
decrease, although not significantly, the NA-induced Ca2+
release via IP3 receptors. These observations could be as a
result of the potassium channel-opening property of BU.
However, this postulation needs to be confirmed by further
investigations.
CONCLUSION
This study conclusively demonstrates that the leaves of G.
procumbens contain putative principles that exhibit a BP-
lowering effect in rats in both in vivo and in vitro studies.
The BP-lowering effect of BU appears to be as a result of
vasodilatation through inhibition of the Ca2+ influx via the
VDCC and ROCC.
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